OneDigital Investment Advisors LLC
13F filer · CIK 0001690370Reported Aug 7, 2026
13F portfolio value$11.8BU.S. long equity reported on 13F
Positions874Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight6.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 7, 2026874 positions | |||||
| $179M | 1.51% | 0.00% | Not reported | Q2 2017 | |
| $120M | 1.01% | 0.00% | Not reported | Q2 2017 | |
| $88.2M | 0.74% | 0.00% | Not reported | Q2 2017 | |
| $85.5M | 0.72% | 0.00% | Not reported | Q2 2017 | |
| $83.2M | 0.70% | 0.00% | Not reported | Q2 2017 | |
| $73.5M | 0.62% | 1.13% | Not reported | Q1 2025 | |
| $66.3M | 0.56% | 0.11% | Not reported | Q2 2017 | |
| $45.6M | 0.38% | Not reported | Not reported | Q2 2017 | |
| $42.3M | 0.36% | Not reported | Not reported | Q4 2018 | |
| $38.6M | 0.33% | 0.00% | Not reported | Q1 2018 | |
| $37.9M | 0.32% | 0.00% | Not reported | Q2 2017 | |
| $36.1M | 0.30% | 4.80% | Not reported | Q3 2022 | |
| $35M | 0.30% | Not reported | Not reported | Q2 2017 | |
| PBPMBSPuramed Bioscience Inc. | $35M | 0.30% | 0.35% | Not reported | Q3 2024 |
| $34.9M | 0.29% | 0.00% | Not reported | Q2 2017 | |
| $32.8M | 0.28% | Not reported | Not reported | Q4 2021 | |
| $31.1M | 0.26% | Not reported | Not reported | Q2 2017 | |
| $26.7M | 0.22% | Not reported | Not reported | Q1 2018 | |
| $24.1M | 0.20% | 0.00% | Not reported | Q1 2018 | |
| $22.9M | 0.19% | 0.02% | Not reported | Q2 2017 | |
| $22.9M | 0.19% | 0.01% | Not reported | Q2 2017 | |
| $22.2M | 0.19% | 0.01% | Not reported | Q2 2017 | |
| $20.9M | 0.18% | 0.00% | Not reported | Q2 2017 | |
| $20.7M | 0.17% | 0.00% | Not reported | Q2 2017 | |
| $19.1M | 0.16% | 0.01% | Not reported | Q2 2017 | |
| $18.5M | 0.16% | Not reported | Not reported | Q2 2017 | |
| $18.3M | 0.15% | 0.00% | Not reported | Q2 2017 | |
| $18.2M | 0.15% | 0.00% | Not reported | Q2 2017 | |
| $18.1M | 0.15% | 0.00% | Not reported | Q2 2017 | |
| $16.9M | 0.14% | 0.00% | Not reported | Q2 2017 | |
| $16.8M | 0.14% | 0.00% | Not reported | Q2 2017 | |
| $16.5M | 0.14% | 0.01% | Not reported | Q2 2017 | |
| $16.5M | 0.14% | 0.00% | Not reported | Q2 2017 | |
| $16.1M | 0.14% | 0.00% | Not reported | Q2 2017 | |
| $16.1M | 0.14% | 2.17% | Not reported | Q2 2017 | |
| $16.1M | 0.14% | 0.00% | Not reported | Q2 2017 | |
| $16M | 0.13% | 0.01% | Not reported | Q4 2022 | |
| $15.6M | 0.13% | 0.00% | Not reported | Q2 2017 | |
| $15.4M | 0.13% | 0.01% | Not reported | Q2 2017 | |
| $15M | 0.13% | Not reported | Not reported | Q4 2023 | |
| $15M | 0.13% | 0.01% | Not reported | Q2 2017 | |
| $13.7M | 0.12% | 0.00% | Not reported | Q2 2017 | |
| $13.6M | 0.11% | 0.02% | Not reported | Q4 2021 | |
| $13.2M | 0.11% | 0.00% | Not reported | Q2 2017 | |
| $12.8M | 0.11% | Not reported | Not reported | Q4 2021 | |
| $11.6M | 0.10% | 0.00% | Not reported | Q2 2017 | |
| $11.5M | 0.10% | 0.05% | Not reported | Q2 2017 | |
| $11.5M | 0.10% | Not reported | Not reported | Q2 2017 | |
| $11.5M | 0.10% | 0.00% | Not reported | Q2 2017 | |
| $11.3M | 0.10% | 0.01% | Not reported | Q2 2017 | |
| Q4 2025Reported Feb 13, 2026915 positions | |||||
| $163M | 1.60% | 0.00% | +0.4% | Q2 2017 | |
| $125M | 1.22% | 0.00% | +4.1% | Q2 2017 | |
| $110M | 1.08% | 0.16% | -0.3% | Q2 2017 | |
| $103M | 1.00% | 0.00% | -2.4% | Q2 2017 | |
| $77.3M | 0.76% | 0.00% | +2.7% | Q2 2017 | |
| $64.1M | 0.63% | 0.00% | +0.5% | Q2 2017 | |
| $39.3M | 0.39% | Not reported | -6.6% | Q2 2017 | |
| $38.5M | 0.38% | 5.52% | -0.2% | Q3 2022 | |
| $36.4M | 0.36% | 0.00% | +2.4% | Q2 2017 | |
| $35.5M | 0.35% | 0.50% | +9.1% | Q1 2025 | |
| $33.8M | 0.33% | 0.00% | +2.8% | Q1 2018 | |
| $33.4M | 0.33% | Not reported | -13.8% | Q4 2018 | |
| $33.2M | 0.33% | Not reported | +8.1% | Q2 2017 | |
| $32.6M | 0.32% | Not reported | +0.7% | Q2 2017 | |
| $31.5M | 0.31% | Not reported | +32.0% | Q1 2018 | |
| $27.9M | 0.27% | Not reported | -1.6% | Q4 2021 | |
| $22.9M | 0.22% | 0.00% | +4.3% | Q2 2017 | |
| $22M | 0.22% | 0.00% | +29.2% | Q2 2017 | |
| $21.7M | 0.21% | Not reported | -2.6% | Q2 2017 | |
| PBPMBSPuramed Bioscience Inc. | $21M | 0.21% | 0.21% | +96.5% | Q3 2024 |
| $19.4M | 0.19% | 0.00% | +19.6% | Q2 2017 | |
| $19.2M | 0.19% | 0.00% | -14.1% | Q2 2017 | |
| $19.1M | 0.19% | 0.01% | +24.9% | Q2 2017 | |
| $19M | 0.19% | 0.02% | -39.7% | Q2 2017 | |
| $17.8M | 0.17% | 0.01% | -0.4% | Q2 2017 | |
| $17.2M | 0.17% | 2.31% | -5.6% | Q2 2017 | |
| $16.6M | 0.16% | 0.01% | +3.4% | Q2 2017 | |
| $15.8M | 0.15% | 0.00% | +4.7% | Q2 2017 | |
| $15.2M | 0.15% | 0.00% | -2.2% | Q2 2017 | |
| $14.1M | 0.14% | 0.01% | +292.9% | Q2 2017 | |
| $14M | 0.14% | 0.00% | -36.0% | Q1 2018 | |
| $13.8M | 0.14% | 0.00% | +47.8% | Q2 2017 | |
| $13.2M | 0.13% | 0.00% | +9.9% | Q2 2017 | |
| $12.9M | 0.13% | 0.00% | +51.4% | Q2 2017 | |
| $12.5M | 0.12% | 0.00% | +38.6% | Q2 2017 | |
| $12.3M | 0.12% | 0.02% | +2.9% | Q4 2021 | |
| $12.1M | 0.12% | 0.00% | -3.5% | Q2 2017 | |
| $12M | 0.12% | 0.00% | +83.0% | Q2 2017 | |
| $11.8M | 0.12% | 0.01% | -5.2% | Q2 2017 | |
| $11.5M | 0.11% | 0.00% | +35.8% | Q2 2017 | |
| $11.2M | 0.11% | 0.01% | +52.1% | Q2 2017 | |
| $11M | 0.11% | 2.61% | Not reported | Q2 2017 | |
| $11M | 0.11% | 0.01% | -1.6% | Q2 2017 | |
| $10.7M | 0.10% | 0.00% | -10.2% | Q2 2017 | |
| $10.6M | 0.10% | 0.01% | +5.1% | Q2 2017 | |
| $10.3M | 0.10% | 0.01% | +2.8% | Q2 2017 | |
| $9.87M | 0.10% | 0.00% | -0.2% | Q2 2017 | |
| $9.43M | 0.09% | 0.04% | +80.5% | Q2 2017 | |
| $8.75M | 0.09% | 0.04% | -4.5% | Q4 2021 | |
| $8.62M | 0.08% | 0.00% | -26.6% | Q2 2017 | |
| Q3 2025Reported Nov 10, 2025923 positions | |||||
| $152M | 1.56% | 0.00% | +2.1% | Q2 2017 | |
| $128M | 1.32% | 0.00% | -0.2% | Q2 2017 | |
| $105M | 1.08% | 0.00% | +5.5% | Q2 2017 | |
| $99.1M | 1.02% | 0.18% | +20.6% | Q2 2017 | |
| $71.6M | 0.73% | 0.00% | -1.2% | Q2 2017 | |
| $49.5M | 0.51% | 0.00% | -1.0% | Q2 2017 | |
| $41.1M | 0.42% | Not reported | -3.7% | Q2 2017 | |
| $38M | 0.39% | 5.53% | -7.1% | Q3 2022 | |
| $37.9M | 0.39% | Not reported | -8.4% | Q4 2018 | |
| $35.3M | 0.36% | 0.46% | +10495.4% | Q1 2025 | |
| $34.8M | 0.36% | 0.00% | -1.0% | Q2 2017 | |
| $32.4M | 0.33% | Not reported | +11.4% | Q2 2017 | |
| $31.3M | 0.32% | 0.00% | +2.1% | Q1 2018 | |
| $29.9M | 0.31% | 0.03% | -0.3% | Q2 2017 | |
| $27.2M | 0.28% | Not reported | -0.8% | Q4 2021 | |
| $24.8M | 0.25% | Not reported | -3.1% | Q2 2017 | |
| $23.9M | 0.25% | Not reported | -24.7% | Q1 2018 | |
| $23.9M | 0.24% | Not reported | -2.9% | Q2 2017 | |
| $20.5M | 0.21% | 0.00% | -1.2% | Q2 2017 | |
| $20.3M | 0.21% | 0.00% | +0.6% | Q2 2017 | |
| $18.2M | 0.19% | 2.45% | -1.0% | Q2 2017 | |
| $17.8M | 0.18% | 0.01% | +15.8% | Q2 2017 | |
| $16.5M | 0.17% | 0.01% | +4.4% | Q1 2018 | |
| $16.4M | 0.17% | 0.00% | -4.0% | Q2 2017 | |
| $16.2M | 0.17% | 0.00% | +1.0% | Q2 2017 | |
| $16M | 0.16% | 0.00% | +1.3% | Q2 2017 | |
| $16M | 0.16% | 0.01% | -2.0% | Q2 2017 | |
| $15.3M | 0.16% | 0.00% | -0.6% | Q2 2017 | |
| $14.6M | 0.15% | 0.00% | +1.5% | Q2 2017 | |
| $13.1M | 0.13% | 0.00% | -2.7% | Q2 2017 | |
| $12.7M | 0.13% | 0.01% | +0.6% | Q2 2017 | |
| $12.1M | 0.12% | 0.02% | -3.0% | Q4 2021 | |
| $12.1M | 0.12% | 0.01% | +63.4% | Q2 2017 | |
| $11.7M | 0.12% | 0.07% | +3.6% | Q1 2024 | |
| $11.6M | 0.12% | 0.00% | -3.2% | Q2 2017 | |
| $11.1M | 0.11% | 0.01% | +4.1% | Q2 2017 | |
| $10.9M | 0.11% | 0.01% | 0.0% | Q2 2017 | |
| PBPMBSPuramed Bioscience Inc. | $10.7M | 0.11% | 0.11% | +60.1% | Q3 2024 |
| $10.4M | 0.11% | 0.00% | -3.8% | Q2 2017 | |
| $10.2M | 0.10% | 0.02% | -0.6% | Q4 2022 | |
| $10M | 0.10% | 0.00% | +0.7% | Q2 2017 | |
| $9.82M | 0.10% | 0.01% | +55.9% | Q2 2017 | |
| $9.49M | 0.10% | 0.00% | -1.2% | Q2 2017 | |
| $9.42M | 0.10% | Not reported | +543.0% | Q1 2018 | |
| $9.21M | 0.09% | 0.00% | +2.8% | Q2 2017 | |
| $8.74M | 0.09% | Not reported | +40.0% | Q1 2018 | |
| $8.5M | 0.09% | 0.00% | -7.1% | Q2 2017 | |
| $8.24M | 0.08% | 0.00% | -2.5% | Q2 2017 | |
| $8.23M | 0.08% | 0.27% | 0.0% | Q2 2022 | |
| $8.06M | 0.08% | 0.00% | -0.3% | Q2 2017 | |
| Q2 2025Reported Aug 7, 2025900 positions | |||||
| $123M | 1.37% | 0.00% | -4.7% | Q2 2017 | |
| $120M | 1.33% | 0.00% | -8.0% | Q2 2017 | |
| $84.3M | 0.94% | 0.00% | +35.1% | Q2 2017 | |
| $72.4M | 0.80% | 0.00% | +1.6% | Q2 2017 | |
| $70.4M | 0.78% | 0.15% | -8.3% | Q2 2017 | |
| $39.6M | 0.44% | Not reported | +11.9% | Q2 2017 | |
| $38M | 0.42% | Not reported | +62.2% | Q4 2018 | |
| $37.9M | 0.42% | 5.95% | +0.3% | Q3 2022 | |
| $36.2M | 0.40% | 0.00% | -13.8% | Q2 2017 | |
| $32.3M | 0.36% | 0.00% | -17.1% | Q2 2017 | |
| $31.5M | 0.35% | Not reported | +29.0% | Q1 2018 | |
| $28.1M | 0.31% | Not reported | -1.8% | Q2 2017 | |
| $27.4M | 0.30% | 0.03% | -0.8% | Q2 2017 | |
| $25.7M | 0.29% | Not reported | +1.4% | Q2 2017 | |
| $25.7M | 0.29% | Not reported | -2.0% | Q4 2021 | |
| $25.6M | 0.28% | 0.00% | -4.0% | Q1 2018 | |
| $19.1M | 0.21% | 0.00% | -5.8% | Q2 2017 | |
| $18.4M | 0.20% | 2.47% | +0.2% | Q2 2017 | |
| $17.9M | 0.20% | Not reported | -8.8% | Q2 2017 | |
| $17.7M | 0.20% | 0.00% | -5.6% | Q2 2017 | |
| $17.1M | 0.19% | 0.00% | -16.4% | Q2 2017 | |
| $16.9M | 0.19% | 0.00% | +15.9% | Q2 2017 | |
| $15.8M | 0.18% | 0.01% | -5.4% | Q2 2017 | |
| $14.8M | 0.16% | 0.01% | +2.5% | Q2 2017 | |
| $13.9M | 0.15% | 0.01% | +21.6% | Q1 2018 | |
| $13.8M | 0.15% | 0.00% | -1.8% | Q2 2017 | |
| $13.3M | 0.15% | 0.02% | -6.0% | Q4 2021 | |
| $13.3M | 0.15% | 0.01% | -0.3% | Q2 2017 | |
| $12.6M | 0.14% | 0.00% | -5.3% | Q2 2017 | |
| $12.4M | 0.14% | 0.00% | -20.8% | Q2 2017 | |
| $12.2M | 0.14% | 0.00% | +18.7% | Q2 2017 | |
| $11.3M | 0.13% | 0.00% | +1.6% | Q2 2017 | |
| $11.2M | 0.12% | 0.01% | +32.5% | Q1 2018 | |
| $11.1M | 0.12% | 0.01% | +356.4% | Q2 2017 | |
| $10.1M | 0.11% | 0.00% | +0.9% | Q2 2017 | |
| $9.35M | 0.10% | 0.00% | +0.2% | Q2 2017 | |
| $9.17M | 0.10% | 0.01% | -7.5% | Q2 2017 | |
| $8.99M | 0.10% | 0.00% | -19.3% | Q2 2017 | |
| $8.84M | 0.10% | 0.07% | -1.9% | Q1 2024 | |
| $8.69M | 0.10% | 0.02% | +9.3% | Q4 2022 | |
| $8.45M | 0.09% | 0.00% | +0.9% | Q2 2017 | |
| $8.38M | 0.09% | 0.00% | -2.6% | Q2 2017 | |
| $8.27M | 0.09% | 0.00% | +6.2% | Q2 2017 | |
| $8.26M | 0.09% | 0.00% | -2.2% | Q2 2017 | |
| $7.7M | 0.09% | 0.00% | -13.1% | Q2 2017 | |
| $7.67M | 0.09% | Not reported | -86.4% | Q4 2023 | |
| $7.64M | 0.08% | 0.00% | -1.3% | Q2 2017 | |
| $7.62M | 0.08% | 0.01% | -0.1% | Q3 2022 | |
| $7.6M | 0.08% | 0.27% | -12.7% | Q2 2022 | |
| $7.32M | 0.08% | 0.01% | -1.4% | Q3 2022 | |
Premium opens every quarter this fund has filed